MONTE ROSA THERAPEUTICS, INC. Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Subordinated Debt SecuritiesIndenture • July 1st, 2022 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 1st, 2022 Company Industry JurisdictionINDENTURE, dated as of [•], 202 , among MONTE ROSA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
OPEN MARKET SALE AGREEMENTSMOpen Market Sale Agreement • July 1st, 2022 • Monte Rosa Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 1st, 2022 Company Industry Jurisdiction